News
16h
New Vision on MSNWHO recommends Uganda-tested HIV prevention drug, issues guidelines on usageThe recommendation comes just weeks after the US Food and Drug Administration (FDA) approved the drug for use. Lenacapavir trials were conducted in Uganda and South Africa and demonstrated 100% ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...
Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...
Trump's aid cuts impact HIV prevention in Africa, leaving vulnerable groups at risk Trump says U.S. pays too much in foreign aid, wants others to help shoulder burden PEPFAR provision of ...
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent effectiveness in trials. Here's how it works, and what it costs.
The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a significant step towards a global rollout that could safeguard millions.
Even though the trial has concluded, Haddock said, he plans to continue receiving lenacapavir injections twice a year, and he hopes the FDA approval will help raise awareness of HIV prevention tools.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.
Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in ...
But a twice-yearly shot of lenacapavir has now become another option in the prevention toolbox – making it the first and only such shot for HIV prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results